30,780 Shares in Pediatrix Medical Group, Inc. (NYSE:MD) Purchased by Proficio Capital Partners LLC

Proficio Capital Partners LLC bought a new position in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 30,780 shares of the company's stock, valued at approximately $404,000.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Illinois Municipal Retirement Fund increased its position in Pediatrix Medical Group by 7.8% in the 4th quarter. Illinois Municipal Retirement Fund now owns 47,409 shares of the company's stock valued at $622,000 after acquiring an additional 3,411 shares during the period. Ieq Capital LLC increased its position in Pediatrix Medical Group by 47.9% in the 4th quarter. Ieq Capital LLC now owns 40,850 shares of the company's stock valued at $536,000 after acquiring an additional 13,233 shares during the period. New York State Common Retirement Fund increased its position in Pediatrix Medical Group by 9.1% in the 4th quarter. New York State Common Retirement Fund now owns 61,211 shares of the company's stock valued at $803,000 after acquiring an additional 5,126 shares during the period. Principal Financial Group Inc. increased its position in Pediatrix Medical Group by 7.5% in the 4th quarter. Principal Financial Group Inc. now owns 551,924 shares of the company's stock valued at $7,241,000 after acquiring an additional 38,306 shares during the period. Finally, Rhumbline Advisers increased its position in Pediatrix Medical Group by 1.7% in the 4th quarter. Rhumbline Advisers now owns 224,701 shares of the company's stock valued at $2,948,000 after acquiring an additional 3,822 shares during the period. Institutional investors and hedge funds own 97.71% of the company's stock.

Remove Ads

Pediatrix Medical Group Price Performance

Shares of NYSE:MD traded down $0.17 during trading on Thursday, hitting $13.75. 688,483 shares of the stock were exchanged, compared to its average volume of 815,843. The company has a fifty day moving average price of $14.13 and a two-hundred day moving average price of $13.38. The company has a market cap of $1.18 billion, a PE ratio of -11.46, a P/E/G ratio of 1.74 and a beta of 1.48. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a 12-month low of $6.62 and a 12-month high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business had revenue of $502.36 million for the quarter, compared to analyst estimates of $486.22 million. On average, analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages have weighed in on MD. Truist Financial lifted their price objective on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a "hold" rating in a report on Friday, February 21st. UBS Group lifted their price objective on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a report on Friday, February 21st. Macquarie began coverage on Pediatrix Medical Group in a report on Monday, December 16th. They issued an "outperform" rating and a $18.00 price objective on the stock. Mizuho lifted their price objective on Pediatrix Medical Group from $13.00 to $15.00 and gave the company a "neutral" rating in a report on Tuesday, November 19th. Finally, StockNews.com raised Pediatrix Medical Group from a "hold" rating to a "buy" rating in a report on Wednesday, January 22nd. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, Pediatrix Medical Group presently has an average rating of "Hold" and an average price target of $17.08.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.